BeiGene, Ltd.
ONC
$221.62
$1.670.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.26B | 3.90B | 3.35B | 3.05B | 2.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.26B | 3.90B | 3.35B | 3.05B | 2.72B |
| Cost of Revenue | 647.71M | 607.64M | 546.54M | 458.27M | 416.12M |
| Gross Profit | 3.61B | 3.29B | 2.80B | 2.59B | 2.30B |
| SG&A Expenses | 1.91B | 1.87B | 1.75B | 1.63B | 1.58B |
| Depreciation & Amortization | -- | -- | -- | -377.80K | -189.80K |
| Other Operating Expenses | 24.60K | 24.60K | 25.15M | 500.90K | 500.90K |
| Total Operating Expenses | 4.57B | 4.48B | 4.24B | 3.92B | 3.79B |
| Operating Income | -313.67M | -586.12M | -892.55M | -864.61M | -1.08B |
| Income Before Tax | -284.88M | -549.20M | -804.06M | -454.95M | -716.49M |
| Income Tax Expenses | 124.88M | 112.97M | 53.22M | 51.86M | 51.05M |
| Earnings from Continuing Operations | -409.75 | -662.17 | -857.27 | -506.81 | -767.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -409.75M | -662.17M | -857.27M | -506.81M | -767.54M |
| EBIT | -313.67M | -586.12M | -892.55M | -864.61M | -1.08B |
| EBITDA | -193.25M | -473.22M | -798.72M | -773.36M | -987.18M |
| EPS Basic | -50.58 | -82.04 | -106.77 | -63.43 | -95.83 |
| Normalized Basic EPS | -1.64 | -3.22 | -6.96 | -4.86 | -6.43 |
| EPS Diluted | -50.58 | -82.84 | -107.57 | -64.22 | -96.63 |
| Normalized Diluted EPS | -1.65 | -3.22 | -6.96 | -4.86 | -6.43 |
| Average Basic Shares Outstanding | 422.85M | 420.20M | 418.02M | 418.26M | 418.20M |
| Average Diluted Shares Outstanding | 32.85M | 32.32M | 32.15M | 32.17M | 32.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -3.54% | -2.19% | -1.69% | -3.07% | -2.03% |